The enduring success of sildenafil has undeniably transformed the drug landscape. However, wagering in companies heavily dependent on biosimilars and the declining patent exclusivity surrounding this https://highkeysocial.com/story6988552/the-blue-pill-and-drugmakers-a-speculative-investment